Recruiting PHASE2 INTERVENTIONAL 1-arm NCT05020912

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Alteration of the Immune Microenvironment in Basal Cell Carcinoma (BCC) Following Photodynamic Therapy (PDT)

Sponsor: Case Comprehensive Cancer Center

Interventions ALA PDT

Updated 11 times since 2021 Last updated: Nov 25, 2025 Started: Dec 13, 2021 Primary completion: Sep 30, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Basal Cell Carcinoma, this trial is actively recruiting participants. The trial is conducted by Case Comprehensive Cancer Center and has accumulated 11 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

11 versions recorded

Dec 2025 — Present [monthly]

Recruiting PHASE2
Dec 2024 — Dec 2025 [monthly]

Recruiting PHASE2
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Dec 2023 — Jul 2024 [monthly]

Recruiting PHASE2

▶ Show 6 earlier versions

Aug 2023 — Dec 2023 [monthly]

Recruiting PHASE2
Apr 2023 — Aug 2023 [monthly]

Recruiting PHASE2
Apr 2022 — Apr 2023 [monthly]

Recruiting PHASE2
Jan 2022 — Apr 2022 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Dec 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE2
Sep 2021 — Dec 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Case Comprehensive Cancer Center

Data source: Case Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States